Results 1 to 10 of about 176,246 (254)

Advances in Immunosuppressive Agents Based on Signal Pathway [PDF]

Frontiers in Pharmacology, 2022
Immune abnormality involves in various diseases, such as infection, allergic diseases, autoimmune diseases, as well as transplantation. Several signal pathways have been demonstrated to play a central role in the immune response, including JAK/STAT, NF ...
Zhiqing Xu, Zhiqing Xu, Ming Chu
doaj   +2 more sources

Failure of primary immunosuppressive agents in uveitis [PDF]

Indian Journal of Ophthalmology
Purpose: This retrospective study aimed to evaluate the effectiveness of various immunomodulatory therapy (IMT) regimens in managing non-infectious uveitis (NIU) and to identify optimal treatment strategies for refractory cases.
Ankush Kawali, Sara Rizvi, Sai Bhakti Mishra, Padmamalini Mahendradas, Rohit Shetty   +4 more
doaj   +2 more sources

Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials [PDF]

Frontiers in Pharmacology
BackgroundImmune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used ...
Yaotan Li, Yaotan Li, Jinyi Hou, Jinyi Hou, Xiaochang Wu, Xiaochang Wu, Chang Liu, Mengqi Zhou, Shijia Lin, Weijing Liu, Weijing Liu, Yaoxian Wang, Yaoxian Wang, Huijuan Zheng, Huijuan Zheng   +14 more
doaj   +2 more sources

Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents [PDF]

Frontiers in Immunology
Pemphigus foliaceus (PF) is a superficial form of pemphigus. Treatment options for PF resemble pemphigus vulgaris, including glucocorticosteroids, immunosuppressive agents and rituximab et al.
Quanhong Zhang, Quanhong Zhang, Lang Yu, Lang Yu, Li Wan, Liuqing Chen, Liuqing Chen, Jinbo Chen, Jinbo Chen   +8 more
doaj   +2 more sources

COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic. [PDF]

J Cosmet Dermatol, 2022
Aryanian Z, Balighi K, Afshar ZM, Zamanian MH, Razavi Z, Hatami P.   +5 more
europepmc   +3 more sources

The relationship between cumulative dose of immunosuppressive agents and COVID-19-associated mucormycosis: A multicenter cross-sectional study. [PDF]

Health Sci Rep, 2022
Rastkar M, SeyedAlinaghi S, Asanjarani B, Siri G, Abdollahi H, Ghadami L, Hasibi M, Khodashahi R, Bagheri A, Asadollahi-Amin A.   +9 more
europepmc   +3 more sources

Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. [PDF]

Expert Opin Drug Metab Toxicol, 2021
Job KM, Roberts JK, Enioutina EY, Illamola SM, Kumar SS, Rashid J, Ward RM, Fukuda T, Sherbotie J, Sherwin CM.   +9 more
europepmc   +3 more sources

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis. [PDF]

Front Pharmacol, 2022
Liu J, Li X, Huang T, Xu G.
europepmc   +2 more sources

Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation. [PDF]

Saudi Pharm J, 2023
Mehmood Y, Shahid H, Abbas M, Farooq U, Farooq U, Ali S, Kazi M.   +6 more
europepmc   +2 more sources

Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? [PDF]

Cancer Cell Int
Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, Asgari Z, Vanan AG, Ghorbaninezhad F, Tahmasebi S.   +9 more
europepmc   +3 more sources